Graves' disease: developments in first-line antithyroid drugs in the young.

Expert Review of Endocrinology & Metabolism
Laura C Lane, Tim Cheetham

Abstract

Introduction: First-line treatment for most young people with Graves' disease (GD) will include the administration of a thionamide antithyroid medication (ATD); Carbimazole (CBZ), Methimazole (MMZ), or rarely, propylthiouracil (PTU). GD is a challenge for families and clinicians because the likelihood of remission following a course of ATD is lower in young people when compared to adults, yet the risk of adverse events is higher. An overall consensus regarding the optimal ATD treatment regimen is lacking; how ATD are prescribed, for how long and how the associated risk of adverse events is managed varies between clinicians, units and nations. This partly reflects clinician and family uncertainty regarding outcomes.Areas covered: This review will focus on some of the key articles published in the field of thionamide ATD in children. It will highlight key issues that need to be discussed with families as well as addressing the approach and controversies in the treatment of GD. This article does not reflect a formal systematic review of the literature.Expert opinion: New strategies in areas such as immunomodulation may see the development of new antithyroid drug treatments that, either in isolation or in combination with thionamid...Continue Reading

References

Jun 25, 1992·The New England Journal of Medicine·L TallstedtA Taube
May 1, 1985·The Journal of Clinical Endocrinology and Metabolism·J I Hamburger
Jan 1, 1987·The New England Journal of Medicine·T H TöttermanI Mendel-Hartvig
Jun 1, 1987·The Journal of Clinical Endocrinology and Metabolism·B M LippeS A Kaplan
Jul 1, 1983·Clinical Immunology and Immunopathology·A P WeetmanR Hall
May 1, 1995·Journal of Gastroenterology and Hepatology·M J Huang, Y F Liaw
Jan 8, 1998·The New England Journal of Medicine·L BartalenaA Pinchera
Oct 16, 1999·Acta Paediatrica·J RazaC G Brook
Oct 19, 1999·Thyroid : Official Journal of the American Thyroid Association·M SegniA M Pasquino
Nov 4, 2000·The Journal of Clinical Endocrinology and Metabolism·L LazarM Phillip
Apr 25, 2001·Clinical Endocrinology·G W Wong, P S Cheng
Sep 10, 2004·The Journal of Clinical Endocrinology and Metabolism·Charles H ReadYusuf Menda
Sep 25, 2004·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Mark W RussoPaul Watkins
Mar 5, 2005·The New England Journal of Medicine·David S Cooper
Sep 1, 2005·Thyroid : Official Journal of the American Thyroid Association·George G J M KuiperTheo J Visser
Sep 29, 2005·European Journal of Endocrinology·G E KrassasW M Wiersinga
Dec 3, 2005·European Journal of Endocrinology·Ellie M WekkingWilmar M Wiersinga
Mar 8, 2007·The Journal of Clinical Endocrinology and Metabolism·James A LeeOrlo H Clark
Mar 27, 2007·Thyroid : Official Journal of the American Thyroid Association·Mary H SamuelsJeri S Janowsky
Mar 29, 2007·The Journal of Clinical Endocrinology and Metabolism·Hirotoshi NakamuraNoboru Hamada
May 4, 2007·Endocrine Reviews·Mario RotondiPaola Romagnani
Sep 8, 2007·Thyroid : Official Journal of the American Thyroid Association·Jessica Smith, Rosalind S Brown
Feb 13, 2008·Pediatrics·Nicole S GlaserUNKNOWN Organization of Pediatric Endocrinologists of Northern California Collaborative Graves' Disease Study Group
Jul 17, 2008·The Journal of Clinical Endocrinology and Metabolism·Florentia KaguelidouUNKNOWN French Childhood Graves' Disease Study Group
May 19, 2009·Thyroid : Official Journal of the American Thyroid Association·Kazuna TakataAkira Miyauchi
Jun 10, 2009·Hormone Research·Florentia KaguelidouJuliane Léger
Jun 11, 2009·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·D GlowackaA K Eckstein
Sep 23, 2009·Clinical Endocrinology·Scott Williamson, Stephen A Greene
Apr 30, 2010·The Journal of Clinical Endocrinology and Metabolism·Scott A Rivkees, Ana Szarfman
Mar 8, 2011·The Journal of Clinical Endocrinology and Metabolism·Andrew J Bauer
Apr 19, 2011·Expert Review of Hematology·Emmanuel AndrèsFrédéric Maloisel
May 20, 2011·The New England Journal of Medicine·Claudio MarcocciUNKNOWN European Group on Graves' Orbitopathy
Jun 28, 2011·Clinical Pediatrics·Revi P Mathew, Daniel J Moore
Aug 19, 2011·The Journal of Clinical Endocrinology and Metabolism·Nicole R van Veenendaal, Scott A Rivkees
Oct 28, 2011·The Journal of Clinical Endocrinology and Metabolism·Juliane LégerUNKNOWN French Childhood Graves' Disease Study Group

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Indian Journal of Endocrinology and Metabolism
Mathew JohnS Sridhar Gomadam
© 2021 Meta ULC. All rights reserved